• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Regorafenib monohydrate Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755754

Regorafenib Monohydrate is a novel oral multikinase inhibitor with IC50 values of 13, 4.2, 46, 22, 7, 1.5, 2.5, 28, 19nM for VEGFR1, murine VEGFR2, murine VEGFR3, PDGFR-beta, KIT, RET, RAF-1, B-RAF and B-RAF(V600E) respectively. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Regorafenib monohydrate, Inhibitor
Full Product Name
Regorafenib monohydrate
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
500.83
Solubility
DMSO: 49mg/mL (97.84mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C21H17ClF4N4O4
SMILES
O.CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1
CAS Number
1019206-88-2
Cell Research
Each cell line was seeded at 0.3x10^5 cells/2ml of DMEM containing 10% FBS in 35mM tissue culture dishes. The cells were incubated for 24 hours to allow attachment, and then the medium was replaced by fresh culture medium containing Regorafenib at increasing concentrations (1uM, 2.5uM, 5uM, 7.5uM and 10uM). In these experimental conditions, the cells were allowed to grow for 72 or 96 hours. Time-course experiments on Hep3B cells were performed with 7.5uM of Regorafenib at short (15, 60, 180 minutes.), middle (24, 48, 72 and 96 h) or long times (up to seven days). When the cells were treated for long times the drug was replaced with a fresh one. Each experiment included a control with the equivalent concentration of DMSO (solvent control) as the one used for adding Regorafenib. Each experiment was performed in triplicate and repeated 3 times. Subsequent analyses were performed at specific Regorafenib concentrations and incubation times [2]. Cell lines:
Kinase Assay
In vitro assays using recombinant VEGFR2 (murine aa785-aa1367), VEGFR3 (murine aa818-aa1363), PDGFR-b (aa561-aa1106), RAF-1 (aa305-aa648) and BRAFV600E (aa409-aa765) kinase domains were performed as previously described. Initial in vitro kinase inhibition profiling was performed at a fixed 1uM compound concentration under Millipore standard conditions [10uM adenosine-50'- triphosphate (ATP) concentration]. Inhibitory concentration of 50% (IC50) values were determined from selected responding kinases, e.g., VEGFR1 and RET. TIE2 kinase inhibition was measured with a homogeneous time-resolved fluorescence (HTRF) assay using a recombinant fusion protein of glutathione-S-transferase, the intracellular domain of TIE2 and the peptide biotin-Ahx-EPKDDAYPLYSDFG as substrate.

Product References and Citations for Regorafenib monohydrate, inhibitor

Wilhelm SM, et al. Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer, 2011, 129(1), 245-255.
Carr BI, et al. Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery. J Cell Physiol, 2013, 228(2), 292-297.
Zopf D, et al. Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models. Cancer Med. 2016 Nov;5(11):3176-3185.

Other Notes

Small volumes of Regorafenib monohydrate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Regorafenib monohydrate purchase

MBS5755754 is an inhibitor targeting Regorafenib monohydrate.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000